Delivery Order SPE2DB20D1100-SPE2DB24FC7M8
Award Date
7/15/24
Potential Completion Date
8/5/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $1,387.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and covers the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract, valued at $1,103.02, is a Delivery Order with a Firm Fixed Price pricing type awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 13, 2024 and was awarded on May 22, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.36 firm fixed-price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022 and was awarded on September 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,295.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,309.06 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The order has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value...
The U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML pharmaceuticals. The $4,590.10 contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has also received an indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML products. The $1,344.27 firm fixed price delivery order contract has an ultimate completion date of October 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is valued at $4,780.00 and covers the procurement of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has a firm fixed price pricing type and an ultimate completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order (SPE2DB24D2100|SPE2DB24FBCPR) with a firm fixed price ceiling value of $2,754.06. The award, issued by the Defense Logistics Agency (DLA), is for the supply of Rhophylac, a prescription medication, with an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.25 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...